These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 12825415
1. [Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci]. Hara T, Araake M, Tsuruoka T, Watabe H. Jpn J Antibiot; 2003 Apr; 56(2):142-7. PubMed ID: 12825415 [Abstract] [Full Text] [Related]
3. [In vitro susceptibilities of clinical isolates of Staphylococcus aureus]. Igari J, Shimoji K, Uezu N, Nakasone I, Taira K, Kakazu R. Jpn J Antibiot; 1988 Sep; 41(9):1205-11. PubMed ID: 3241323 [Abstract] [Full Text] [Related]
4. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin in combination against methicillin-resistant Staphylococcus aureus studies by checkerboard MIC method and disc diffusion method using discs containing both drugs]. Matsuo K, Uete T. Jpn J Antibiot; 1993 Feb; 46(2):130-41. PubMed ID: 8331773 [Abstract] [Full Text] [Related]
5. [Antimicrobial activity of fosfomycin under various conditions against standard strains, beta-lactam resistant strains, and multidrug efflux system mutants]. Mikuniya T, Hiraishi T, Maebashi K, Ida T, Takata T, Hikida M, Yamada S, Gotoh N, Nishino T. Jpn J Antibiot; 2005 Apr; 58(2):105-22. PubMed ID: 15997654 [Abstract] [Full Text] [Related]
7. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics]. Matsuo K, Uete T. Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908 [Abstract] [Full Text] [Related]
8. [Studies on phage type, beta-lactamase activity and sensitivity of multiple drug-resistant Staphylococcus aureus isolated from clinical specimens to cefmetazole]. Toyonaga Y, Kurosu Y, Sugita M, Kumagai K, Hori M, Hoshina S, Kurosaka K, Nishiyama H, Shinohara N, Takahashi T, Deguchi K 210 P. Jpn J Antibiot; 1982 Jul; 35(7):1673-85. PubMed ID: 6217356 [Abstract] [Full Text] [Related]
9. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method]. Matsuo K, Uete T. Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676 [Abstract] [Full Text] [Related]
14. [Study on the drug sensitivity of multiple drug-resistant Staphylococcus aureus]. Deguchi K, Fukayama S, Nishimura Y, Yokota N, Tanaka S, Oda S, Matsumoto Y, Ikegami R, Satoh K, Toyonaga Y. Jpn J Antibiot; 1985 Aug; 38(8):2163-70. PubMed ID: 3852898 [Abstract] [Full Text] [Related]
16. [Correlation between coagulase typing and antibiotic susceptibility in methicillin resistant Staphylococcus aureus]. Takesue Y, Yokoyama T, Kodama T, Fujimoto M, Sewake H, Murakami Y. Nihon Geka Gakkai Zasshi; 1989 Jan; 90(1):5-11. PubMed ID: 2649789 [Abstract] [Full Text] [Related]
17. Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin. Nakazawa H, Kikuchi Y, Honda T, Isago T, Nozaki M. J Infect Chemother; 2003 Dec; 9(4):304-9. PubMed ID: 14691650 [Abstract] [Full Text] [Related]
18. [In vitro synergistic effects of tazobactam/piperacillin with various antibiotics]. Nishida K, Niidome K, Hashimoto M, Otsuki M, Nishino T. Jpn J Antibiot; 1994 Oct; 47(10):1348-62. PubMed ID: 7807695 [Abstract] [Full Text] [Related]